Uniprot AC Entrez ID Gene Name Disease Cell Type PTM Type State Position PMID P01024 718 C3 CPAMD1 Skin cutaneous melanoma Phosphorylation N S38 P01024 718 C3 CPAMD1 Esophageal cancer Phosphorylation N S70 P01024 718 C3 CPAMD1 Uterine cancer Phosphorylation N S297 P01024 718 C3 CPAMD1 hemolytic-uremic syndrome Ubiquitination N K600 P01024 718 C3 CPAMD1 Prostate adenocarcinoma Phosphorylation N S672 P01024 718 C3 CPAMD1 Skin cutaneous melanoma Phosphorylation N S672 P01024 718 C3 CPAMD1 Stomach adenocarcinoma Phosphorylation N S672 P01024 718 C3 CPAMD1 Hepatocellular carcinoma Phosphorylation N S742 P01024 718 C3 CPAMD1 Head and neck squamous cell carcinoma Glycosylation N N939 P01024 718 C3 CPAMD1 Skin cutaneous melanoma Glycosylation N N939 P01024 718 C3 CPAMD1 Head and neck squamous cell carcinoma N-linked glycosylation N N939 P01024 718 C3 CPAMD1 Skin cutaneous melanoma N-linked glycosylation N N939 P01024 718 C3 CPAMD1 Bladder urothelial carcinoma Phosphorylation N S968 P01024 718 C3 CPAMD1 Uterine cancer Phosphorylation N S968 P01024 718 C3 CPAMD1 Breast invasive carcinoma Phosphorylation N T1031 P01024 718 C3 CPAMD1 Stomach adenocarcinoma Phosphorylation N T1031 P01024 718 C3 CPAMD1 Bladder urothelial carcinoma Phosphorylation N S1321 P01024 718 C3 CPAMD1 Melanoma Phosphorylation N S1321 P01024 718 C3 CPAMD1 Skin cutaneous melanoma Phosphorylation N S1321 P01024 718 C3 CPAMD1 Ovarian cancer Phosphorylation N T1341 P01024 718 C3 CPAMD1 Sarcoma Phosphorylation N T1341 P01024 718 C3 CPAMD1 Skin cutaneous melanoma Phosphorylation N T1341 P01024 718 C3 CPAMD1 Ovarian cancer Phosphorylation N S1343 P01024 718 C3 CPAMD1 Skin cutaneous melanoma Phosphorylation N S1571 P01024 718 C3 CPAMD1 Brain cancer Phosphorylation N S1573 P01024 718 C3 CPAMD1 Skin cutaneous melanoma Phosphorylation N S1573 P01024 718 C3 CPAMD1 Bladder urothelial carcinoma Phosphorylation N S1586 P01024 718 C3 CPAMD1 Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N S1586 P01024 718 C3 CPAMD1 Cholangiocarcinoma Phosphorylation N S1586 P01024 718 C3 CPAMD1 Stomach adenocarcinoma Phosphorylation N S1586 P01024 718 C3 CPAMD1 Lung squamous cell carcinoma N-linked glycosylation N N1617 P05156 3426 CFI IF Atypical hemolytic-uremic syndrome Glycosylation N N70 P05156 3426 CFI IF Atypical hemolytic-uremic syndrome N-linked glycosylation N N70 P05156 3426 CFI IF Hepatocellular carcinoma Phosphorylation N S90 P05156 3426 CFI IF Skin cutaneous melanoma Phosphorylation N S90 P05156 3426 CFI IF Atypical hemolytic-uremic syndrome Glycosylation N N103 P05156 3426 CFI IF Atypical hemolytic-uremic syndrome N-linked glycosylation N N103 P05156 3426 CFI IF Skin cutaneous melanoma Glycosylation N N177 P05156 3426 CFI IF Skin cutaneous melanoma N-linked glycosylation N N177 P05156 3426 CFI IF Complement factor I deficiency Phosphorylation N Y421 P05156 3426 CFI IF hemolytic-uremic syndrome Phosphorylation N Y421 P05156 3426 CFI IF Atypical hemolytic-uremic syndrome Glycosylation N N464 P05156 3426 CFI IF Cervical squamous cell carcinoma and endocervical adenocarcinoma Glycosylation N N464 P05156 3426 CFI IF Atypical hemolytic-uremic syndrome N-linked glycosylation N N464 P05156 3426 CFI IF Cervical squamous cell carcinoma and endocervical adenocarcinoma N-linked glycosylation N N464 P05156 3426 CFI IF Stomach adenocarcinoma N-linked glycosylation N N494 P05156 3426 CFI IF Skin cutaneous melanoma N-linked glycosylation N N536 P08603 3075 CFH HF HF1 HF2 Head and neck squamous cell carcinoma Glycosylation N N217 P08603 3075 CFH HF HF1 HF2 Hepatocellular carcinoma Glycosylation N N217 P08603 3075 CFH HF HF1 HF2 Lung squamous cell carcinoma Glycosylation N N217 P08603 3075 CFH HF HF1 HF2 Skin cutaneous melanoma Glycosylation N N217 P08603 3075 CFH HF HF1 HF2 Stomach adenocarcinoma Glycosylation N N217 P08603 3075 CFH HF HF1 HF2 Head and neck squamous cell carcinoma N-linked glycosylation N N217 P08603 3075 CFH HF HF1 HF2 Hepatocellular carcinoma N-linked glycosylation N N217 P08603 3075 CFH HF HF1 HF2 Lung squamous cell carcinoma N-linked glycosylation N N217 P08603 3075 CFH HF HF1 HF2 Skin cutaneous melanoma N-linked glycosylation N N217 P08603 3075 CFH HF HF1 HF2 Stomach adenocarcinoma N-linked glycosylation N N217 P08603 3075 CFH HF HF1 HF2 Head and neck squamous cell carcinoma Phosphorylation N S411 P08603 3075 CFH HF HF1 HF2 Hepatocellular carcinoma Phosphorylation N S411 P08603 3075 CFH HF HF1 HF2 Rectum adenocarcinoma Phosphorylation N S411 P08603 3075 CFH HF HF1 HF2 Skin cutaneous melanoma Phosphorylation N S411 P08603 3075 CFH HF HF1 HF2 Complement factor H deficiency Phosphorylation N T427 P08603 3075 CFH HF HF1 HF2 Prostate adenocarcinoma N-linked glycosylation N N529 P08603 3075 CFH HF HF1 HF2 Lung adenocarcinoma N-linked glycosylation N N718 P08603 3075 CFH HF HF1 HF2 Skin cutaneous melanoma N-linked glycosylation N N718 P08603 3075 CFH HF HF1 HF2 Bladder urothelial carcinoma N-linked glycosylation N N802 P08603 3075 CFH HF HF1 HF2 Skin cutaneous melanoma N-linked glycosylation N N802 P08603 3075 CFH HF HF1 HF2 Kidney renal papillary cell carcinoma N-linked glycosylation N N822 P08603 3075 CFH HF HF1 HF2 Skin cutaneous melanoma Glycosylation N N882 P08603 3075 CFH HF HF1 HF2 Stomach adenocarcinoma Glycosylation N N882 P08603 3075 CFH HF HF1 HF2 Skin cutaneous melanoma N-linked glycosylation N N882 P08603 3075 CFH HF HF1 HF2 Stomach adenocarcinoma N-linked glycosylation N N882 P08603 3075 CFH HF HF1 HF2 Lung adenocarcinoma Glycosylation N N911 P08603 3075 CFH HF HF1 HF2 Lung adenocarcinoma N-linked glycosylation N N911 P08603 3075 CFH HF HF1 HF2 Breast invasive carcinoma Glycosylation N N1029 P08603 3075 CFH HF HF1 HF2 Cervical squamous cell carcinoma and endocervical adenocarcinoma Glycosylation N N1029 P08603 3075 CFH HF HF1 HF2 Breast invasive carcinoma N-linked glycosylation N N1029 P08603 3075 CFH HF HF1 HF2 Cervical squamous cell carcinoma and endocervical adenocarcinoma N-linked glycosylation N N1029 P08603 3075 CFH HF HF1 HF2 Skin cutaneous melanoma N-linked glycosylation N N1095 P08603 3075 CFH HF HF1 HF2 Head and neck squamous cell carcinoma Phosphorylation N S1170 P08603 3075 CFH HF HF1 HF2 hemolytic-uremic syndrome Phosphorylation N S1170 P08603 3075 CFH HF HF1 HF2 hemolytic-uremic syndrome Phosphorylation N T1193 P08603 3075 CFH HF HF1 HF2 Brain lower grade glioma Phosphorylation N S1196 P08603 3075 CFH HF HF1 HF2 Cervical squamous cell carcinoma Phosphorylation N S1196 P08603 3075 CFH HF HF1 HF2 Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N S1196 P08603 3075 CFH HF HF1 HF2 Stomach adenocarcinoma Phosphorylation N S1196 P08603 3075 CFH HF HF1 HF2 hemolytic-uremic syndrome Phosphorylation N S1196 P15529 4179 CD46 MCP MIC10 Breast invasive carcinoma Ubiquitination N K66 P15529 4179 CD46 MCP MIC10 Lung squamous cell carcinoma Ubiquitination N K66 P15529 4179 CD46 MCP MIC10 Skin cutaneous melanoma Ubiquitination N K66 P15529 4179 CD46 MCP MIC10 Stomach adenocarcinoma Ubiquitination N K153 P15529 4179 CD46 MCP MIC10 Stomach adenocarcinoma Ubiquitination N K159 P15529 4179 CD46 MCP MIC10 Hepatocellular carcinoma Ubiquitination N K167 P15529 4179 CD46 MCP MIC10 hemolytic-uremic syndrome Ubiquitination N K167 P15529 4179 CD46 MCP MIC10 Cholangiocarcinoma Ubiquitination N K224 P15529 4179 CD46 MCP MIC10 Colorectal cancer Ubiquitination N K224 P15529 4179 CD46 MCP MIC10 Bladder urothelial carcinoma Ubiquitination N K237 P15529 4179 CD46 MCP MIC10 Cholangiocarcinoma Ubiquitination N K237 P15529 4179 CD46 MCP MIC10 hemolytic-uremic syndrome Ubiquitination N K237 P52429 8526 DGKE DAGK5 Breast cancer Acetylation N K101 P52429 8526 DGKE DAGK5 Bladder urothelial carcinoma Ubiquitination N K109 P52429 8526 DGKE DAGK5 Transitional cell carcinoma Ubiquitination N K109 P52429 8526 DGKE DAGK5 Lung squamous cell carcinoma Ubiquitination N K169 P52429 8526 DGKE DAGK5 Lung adenocarcinoma Ubiquitination N K176 P52429 8526 DGKE DAGK5 Hepatocellular carcinoma Ubiquitination N K212 P52429 8526 DGKE DAGK5 Skin cutaneous melanoma Ubiquitination N K212 P52429 8526 DGKE DAGK5 Hepatocellular carcinoma Ubiquitination N K215 P52429 8526 DGKE DAGK5 Skin cutaneous melanoma Ubiquitination N K215 P52429 8526 DGKE DAGK5 Hepatocellular carcinoma Ubiquitination N K254 P52429 8526 DGKE DAGK5 Skin cutaneous melanoma Ubiquitination N K254 P52429 8526 DGKE DAGK5 Stomach adenocarcinoma Ubiquitination N K254 P52429 8526 DGKE DAGK5 hemolytic-uremic syndrome Phosphorylation N Y269 P52429 8526 DGKE DAGK5 Breast adenocarcinoma Ubiquitination N K351 P52429 8526 DGKE DAGK5 Kidney renal papillary cell carcinoma Ubiquitination N K351 P52429 8526 DGKE DAGK5 Brain lower grade glioma Ubiquitination N K392 P52429 8526 DGKE DAGK5 Breast invasive carcinoma Ubiquitination N K392 P52429 8526 DGKE DAGK5 Bladder urothelial carcinoma Ubiquitination N K404 P52429 8526 DGKE DAGK5 Skin cutaneous melanoma Ubiquitination N K404 Q96EU7 29071 C1GALT1C1 COSMC HSPC067 MSTP143 UNQ273/PRO310 Polyagglutinable erythrocyte syndrome Ubiquitination N K54 Q96EU7 29071 C1GALT1C1 COSMC HSPC067 MSTP143 UNQ273/PRO310 Skin cutaneous melanoma Ubiquitination N K54 Q96EU7 29071 C1GALT1C1 COSMC HSPC067 MSTP143 UNQ273/PRO310 Lung adenocarcinoma Phosphorylation N S81 Q96EU7 29071 C1GALT1C1 COSMC HSPC067 MSTP143 UNQ273/PRO310 Lung squamous cell carcinoma Phosphorylation N S81 Q96EU7 29071 C1GALT1C1 COSMC HSPC067 MSTP143 UNQ273/PRO310 Uterine corpus endometrial carcinoma Ubiquitination N K92 Q96EU7 29071 C1GALT1C1 COSMC HSPC067 MSTP143 UNQ273/PRO310 hemolytic-uremic syndrome Ubiquitination N K92 Q96EU7 29071 C1GALT1C1 COSMC HSPC067 MSTP143 UNQ273/PRO310 Polyagglutinable erythrocyte syndrome Ubiquitination N K96 Q96EU7 29071 C1GALT1C1 COSMC HSPC067 MSTP143 UNQ273/PRO310 Uterine corpus endometrial carcinoma Ubiquitination N K96 Q96EU7 29071 C1GALT1C1 COSMC HSPC067 MSTP143 UNQ273/PRO310 Cervical squamous cell carcinoma and endocervical adenocarcinoma Ubiquitination N K127 Q96EU7 29071 C1GALT1C1 COSMC HSPC067 MSTP143 UNQ273/PRO310 Colon adenocarcinoma Ubiquitination N K127 Q96EU7 29071 C1GALT1C1 COSMC HSPC067 MSTP143 UNQ273/PRO310 Head and neck squamous cell carcinoma Ubiquitination N K127 Q96EU7 29071 C1GALT1C1 COSMC HSPC067 MSTP143 UNQ273/PRO310 Bladder urothelial carcinoma Ubiquitination N K161 Q96EU7 29071 C1GALT1C1 COSMC HSPC067 MSTP143 UNQ273/PRO310 Breast invasive carcinoma Ubiquitination N K216 Q96EU7 29071 C1GALT1C1 COSMC HSPC067 MSTP143 UNQ273/PRO310 Polyagglutinable erythrocyte syndrome Ubiquitination N K216 Q96EU7 29071 C1GALT1C1 COSMC HSPC067 MSTP143 UNQ273/PRO310 Renal cell carcinoma Ubiquitination N K216 Q96EU7 29071 C1GALT1C1 COSMC HSPC067 MSTP143 UNQ273/PRO310 Breast invasive carcinoma Ubiquitination N K221 Q96EU7 29071 C1GALT1C1 COSMC HSPC067 MSTP143 UNQ273/PRO310 Polyagglutinable erythrocyte syndrome Ubiquitination N K221 Q96EU7 29071 C1GALT1C1 COSMC HSPC067 MSTP143 UNQ273/PRO310 Renal cell carcinoma Ubiquitination N K221 Q96EU7 29071 C1GALT1C1 COSMC HSPC067 MSTP143 UNQ273/PRO310 Uterine corpus endometrial carcinoma Ubiquitination N K249 P15529 4179 CD46 MCP MIC10 Lymphoma Phosphorylation P 8649859